CD80 and rheumatoid arthritis: We took advantage of murine cells without IL-26 and treated cells with human IL-26 recombinant protein, IL-4, or IFNγ, then analyzed them with CD80 cell surface marker and IL-9 and IL-17A cytokines, which are dominantly expressed in RA patients.